# Integrated DNA Technologies (IDT) "spike" primer sets and amplicon panels.

Canonical: https://abierto.us/opportunities/75d30124q78171

- Solicitation number: 75D30124Q78171
- Notice type: Presolicitation
- Status: Awarded to Integrated Dna Technologies, Inc.
- Department: Department of Health and Human Services
- Agency: Centers for Disease Control and Prevention
- Contracting office: CDC Office of Acquisition Services (75D301)
- NAICS: 541380 Testing Laboratories and Services
- Product or service code: 6640 Laboratory Equipment and Supplies
- Place of performance: Atlanta, Georgia
- City: Atlanta. https://abierto.us/cities/atlanta-ga-1304000
- First posted: August 2, 2024
- Last posted: August 2, 2024
- SAM.gov: https://sam.gov/workspace/contract/opp/6bb07bdf91c4489a8d9125226f061390/view

## Description

The Centers for Disease Control and Prevention (CDC) intends to award a sole source contract to Integrated Data Technologies 1710 COMMERCIAL PARK CORALVILLE, IA 52241 This sole source award will be for proprietary kits for whole genome sequencing of SARS-CoV-2. The Centers for Disease Control and Prevention has a requirement for spike primer sets and amplicon panel products. CDC needs to perform sequencing for surveillance of viruses to monitor for vaccine efficacy and assist in vaccine formulation decisions.

IDT is the only manufacturer that makes the “XGEN” technology that has been validated by CORVD and DSLR. All laboratories at CDC are required to validate research, surveillance, and diagnostic assays. Performing validation of a new kit would take upwards of 12 months to approval, which would hinder the program's work for an entire year. This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b)(1).

Integrated Data Technologies is the only source capable of fulfilling this requirement. Interested persons may identify their interest and capability to respond to the requirement or submit proposals. This notice of intent is not a request for competitive quotations; however, all quotations / responses received within fifteen (15) days of the issuance of this notice will be considered by the government.

A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any response should be emailed to contract specialist at ttu3@cdc.gov. Questions or responses will not be accepted by phone.

## Award on USAspending

- Recipient: Integrated Dna Technologies, Inc. (UEI P55FTN1UMYZ1)
- Contract: 75D30124P20031, purchase order
- Obligated: $187,940.00
- Competition: Not Competed Under SAP, 1 offers received
- Link: solicitation number 75D30124Q78171 equals the FPDS solicitation identifier; same awarding office 75D301 (high confidence)
- Record: https://www.usaspending.gov/award/CONT_AWD_75D30124P20031_7523_-NONE-_-NONE-/


## Publications

- August 2, 2024: Presolicitation, due August 19, 2024 at 8:00 AM EDT. Notice 6bb07bdf91c4489a8d9125226f061390. https://sam.gov/workspace/contract/opp/6bb07bdf91c4489a8d9125226f061390/view

## Points of contact

- Cole Mullis, ttu3@cdc.gov, 7704881596

---
Source: SAM.gov Contract Opportunities bulk extract and USAspending.gov award data. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/75d30124q78171.